Blog
RSS FeedPosted by Michael Wonder on 13 Jun 2021
Unaffordable treatment for severe malaria highlights U.S. drug market pitfalls
11 June 2021 - When Eli Lilly announced in 2017 that it would stop producing quinidine, it was the only ...
Posted by Michael Wonder on 08 Jun 2021
Biogen and Eisai launch multiple initiatives to help patients with Alzheimer’s disease access Aduhelm
7 June 2021 - Value based agreements in progress with Cigna and other payers. ...
Posted by Michael Wonder on 28 Sep 2020
Trump seeks boost from seniors with $200 drug discount coupons
27 September 2020 - President Trump is throwing a pre-election curveball aimed at seniors with a surprise announcement on Thursday ...
Posted by Michael Wonder on 08 Aug 2020
Hard questions as scientists and governments seek COVID-19 vaccines
8 August 2020 - They must work out how much to invest, and how best to distribute the goods. ...
Posted by Michael Wonder on 20 Jul 2020
Gene therapy shows promise for haemophilia, but could be most expensive U.S. drug ever
20 June 2020 - Jack Grehan, who was born with hemophilia, used to inject himself every couple of days with ...
Posted by Michael Wonder on 21 Apr 2020
Here’s why a COVID-19 vaccine could end up costing you a small fortune
21 April 2020 - Things have gone from bad to worse for Brian Helstien. For a decade, he’s been grappling ...
Posted by Michael Wonder on 16 Apr 2020
Lower-priced versions of Humalog Mix75/25 KwikPen and Humalog Junior KwikPen now available
16 April 2020 - Non-branded insulins have a 50% lower list price than branded versions. ...
Posted by Michael Wonder on 24 Mar 2020
Updates from Lilly about insulin supply and affordability
24 March 2020 - To keep the diabetes community informed about important developments from the COVID-19 crisis, Eli Lilly today is ...
Posted by Michael Wonder on 03 Mar 2020
Extended-release drugs could be costing U.S. health care system billions
1 March 2020 - If doctors prescribed short-acting medications that must be taken twice a day instead of once-a-day extended-release ...
Posted by Michael Wonder on 16 Feb 2020
After a new version of a decades-old drug gets orphan status, the price suddenly skyrockets
12 February 2020 - For years, hospitals and clinics have used an injectable medicine called dehydrated alcohol to treat such ...
Posted by Michael Wonder on 19 Dec 2019
Lilly launches campaign to increase awareness of insulin cost saving options
19 December 2019 - Letter from CEO urges people to call the Lilly Diabetes Solution Center. ...
Posted by Michael Wonder on 07 Nov 2019
The U.S. insulin crisis — rationing a lifesaving medication discovered in the 1920s
7 November 2019 - The members of the team that discovered insulin sold the patent to the University of Toronto for ...
Posted by Michael Wonder on 06 Nov 2019
Innovation and access at the mercy of payment policy: the future of chimeric antigen receptor therapies
1 November 2019 - In 2017, the US FDA approved the first chimeric antigen receptor therapies (CAR-Ts), tisagenlecleucel and axicabtagene ...
Posted by Michael Wonder on 06 Nov 2019
One shot drug to end Sicilian curse comes at $1.8 million cost
5 November 2019 - A new targeted gene therapy shows the promise and pitfalls of medical advances. ...
Posted by Michael Wonder on 27 Oct 2019
Making life-saving medical treatments more affordable
25 October 2019 - Recent years have brought significant innovation in potentially curative therapies for several diseases. To expedite patient ...